“…XCR1 + CD34-DC expressed the molecular signature characteristic of XCR1 + bDC, including the chemokine receptor XCR1, which likely promotes physical interactions with CD8 + T cells (8,13), the endocytic receptor CLEC9A, which promotes crosspresentation of Ag derived from dying cells (43), the adhesion receptor CADM1, which may promote the induction of CTL responses (44), and the pattern recognition receptor TLR3, which allows sensing of dsRNA including responsiveness to the synthetic adjuvant PolyI:C. CD1c and CD141 are not reliable markers of human DC subsets, because they were expressed on all the three in vitro-derived DC subsets studied in this work, consistent with similar observations reported for ex vivo-isolated human DC subsets (7,11,42). Hence, flow cytometry assessment of cell surface expression of the discriminative markers XCR1 or CLEC9A and CADM1, or gene expression profiling, are critical to ensure the identity of HLA-DR + CD141 + cells in humans (7,8,11,36).…”